Gregory Critchfield

Gregory C.
Critchfield is Co-Chief Executive Officer at EarlyDiagnostics, Inc. since 2024.
He is Director at Sera Prognostics, Inc. since 2023.
He is Director at Epic Sciences, Inc. since 2015.
He serves on the Board of Strategic Advisors at Excel Medical Ventures LLC.
Former roles include Chairman at Saladax Biomedical, Inc. from 2011 to 2014.
Executive Chairman at Horizon Lines LLC.
Chairman-Section at National Institutes of Health.
Director at BioTrove, Inc. from 2007 to 2009.
Director at Nodality, Inc. from 2010 to 2016.
Lead Independent Director at Metamark Genetics, Inc. from 2012 to 2016.
Director at Lantos Technologies, Inc. from 2015 to 2016.
Director-Clinical Pathology at Intermountain Health (Utah).
Independent Director at Integrated Diagnostics, Inc. from 2010 to 2016.
Director at American Clinical Laboratory Association.
President & Director at Myriad Genetic Laboratories, Inc. from 1998 to 2010.
Director at BIOCIUS Life Sciences, Inc. from 2010 to 2011.
Director at Condor Therapeutics, Inc. Chief Medical & Science Officer, Senior VP at Quest Diagnostics, Inc. from 1995 to 1998.
Education includes undergraduate degree from Brigham Young University in 1976, graduate degree from the University of Minnesota in 1985, and a doctorate from the University of Utah School of Medicine.